SARMs, or selective androgen receptor modulators, are designed to provide muscle-building benefits without the masculinizing effects of testosterone. While they hold promise for various applications, including potential use in women and children, none are FDA approved, and many have been discontinued due to negative side effects. The distinction between SARMs and peptides is crucial, as both are considered research chemicals, but their mechanisms and intended uses differ.
